http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108367080-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-3353
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-3358
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-6615
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-117
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-6615
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-50
filingDate 2016-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108367080-B
titleOfInvention Inositol Derivatives for Pathological Crystallization
abstract The present invention relates to inositol derivatives which are covalently used in the treatment or prevention of disorders associated with pathological calcium crystals such as cardiovascular calcification, nephrocalcinosis, cutaneous calcinosis, chondrocalcinosis and nephrolithiasis Modified with one, two or three solubility functional groups, especially polyethylene glycol moieties.
priorityDate 2015-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21585117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454417319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410443642
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID27421
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID81642
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415716027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10080320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416027229
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450102629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415732477
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID368
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24632
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415758737
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522661
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100334180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222301
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID590018
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447522799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412232735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID169056
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID820497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410135424
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8626236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505

Total number of triples: 70.